News & Updates

Show Multimedia Only
Donanemab delays Alzheimer's disease progression over 3 years Donanemab delays Alzheimer's disease progression over 3 years

Donanemab delays Alzheimer's disease progression over 3 years

04 Jun 2026 byKanas Chan

Donanemab administered for a limited duration continues to slow clinical progression in patients with early symptomatic Alzheimer’s disease (AD) over 3 years, according to Professor Chaur-Jong Hu of the Department of Neurology, Taipei Medical University, who spoke at Advances in Medicine (AIM) 2026. 

04 Jun 2026
Blood test detects signs of Alzheimer’s disease in midlife

Blood test detects signs of Alzheimer’s disease in midlife

02 Jun 2026 byKanas Chan

Blood test can identify signs of accumulation of highly accurate Alzheimer’s Disease (AD)–associated biomarkers in the brains of middle-aged adults, a large community-based cohort study has shown. 

02 Jun 2026
Diet, exercise help improve erectile function

Diet, exercise help improve erectile function

29 May 2026 byStephen Padilla

Adult men with erectile dysfunction may benefit from diet- and exercise-based interventions, which in a recent study have shown to yield modest but significant improvements in erectile function.

29 May 2026